American Society of Clinical Oncology

SHERPA: White

People

  1. Gonen
    Gonen
  2. Miller
    Miller
  3. Motzer
    Motzer
  4. Saltz
    Saltz
  5. Scher
    Scher
  6. Kelsen
    Kelsen
  7. Kris
    Kris
  8. Schwartz
    Schwartz
  9. Hudis
    Hudis
  10. Norton
    Norton

Groups

  1. Department of Medicine (91)
  2. Solid Tumor Oncology Division (83)
  3. Surgery (49)
  4. Survivorship Research (44)
  5. Epidemiology and Biostatistics (28)
  6. Genitourinary Oncology Service (27)
  7. GSK Faculty (25)
  8. Population Sciences Research Program (24)
  9. Biostatistics Service (23)
  10. Nursing (23)
Search Within
  1. "2004"
Formats
  1. Meeting Abstract (115)
  2. Journal Article (55)
Groups
  1. Department of Medicine (91)
  2. Solid Tumor Oncology Division (83)
  3. Surgery (49)
  4. Survivorship Research (44)
  5. Epidemiology and Biostatistics (28)
  6. Genitourinary Oncology Service (27)

More Groups

People
  1. David Spriggs (10)
  2. Mithat Gonen (10)
  3. Vincent Miller (10)
  4. Gary Schwartz (9)
  5. Howard Scher (9)
  6. Leonard Saltz (9)

More People

Years
  1. 2004 (170)
Publications
  1. Journal of Clinical Oncology (170)

Results (170)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Burnout in the practice of oncology: Results of a follow-up survey
    Meeting Abstract

    Whippen, D. A.; Zuckerman, E. L.; Andersen, J. W.; Kamin, D. Y.; Holland, J. C.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Pentostatin and cyclophosphamide compared to pentostatin, cyclophosphamide, and rituximab as salvage therapy for patients with chronic lymphocytic leukemia
    Meeting Abstract

    Weiss, M. A.; Lamanna, N.; Kalaycio, M.; Jurcic, J.; Maslak, P.; Gencarelli, A.; Scheinberg, D.; Horgan, D.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Novel methodology of response assessment in hepatocellular carcinoma (HCC) - Assessing response by change in tumor enhancement in distinction from conventional means
    Meeting Abstract

    Wang, L.; Abou-Alfa, G. K.; Liu, F.; Saltz, L. B.; Kalaigian, J.; Zhao, B.; Colville, J.; Nyoro, J.; Schwartz, B.; Schwartz, L.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • A novel antifolate 10-propargyl-10-deazaaminopterin (PDX) displays synergistic effects with gemcitabine in non-Hodgkin's lymphoma models in vitro and in vivo
    Meeting Abstract

    Vrhovac, R.; Toner, L. E.; Smith, E. A.; O'Connor, O. A.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • 17-allylamino-17-demethoxygeldanamycin (17-AAG) abrogates the G(2)/M cell cycle checkpoint by down-regulating chk1 and selectively sensitizes tumor cells with defective p53 to topoisomerase I poison
    Meeting Abstract

    Tse, A. N.; Solit, D.; Rosen, N.; Schwartz, G.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • cDNA screening to identify genes correlated with SCCRO-associated angiogenesis and metastasis in squamous cell carcinoma of the lung
    Meeting Abstract

    Talbot, S. G.; Sarkaria, I. S.; Socci, N. D.; Maghami, E.; Dudas, M.; Ghossein, R. A.; Viale, A.; Azzoli, C. G.; Rusch, V. W.; Singh, B.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Double-blind, randomized trial of granulocyte-colony stimulating factor (GCSF) versus (v.) placebo during postoperative radiation (RT) for advanced resectable squamous cell head and neck cancer (SCCHN): Impact on mucositis
    Meeting Abstract

    Su, Y. B.; Vickers, A.; Zelefsky, M. J.; Kraus, D. H.; Shaha, A. R.; Shah, J. P.; Lake, S.; Harrison, L. B.; Bosl, G. J.; Pfister, D. G.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Primary retroperitoneal lymph node dissection (RPLND) for non-seminomatous germ-cell tumor (NSGCT): Impact of trends in patient selection on retroperitoneal pathology and outcome
    Meeting Abstract

    Stephenson, A. J.; Bosl, G. J.; Motzer, R. J.; Bajorin, D. F.; Stasi, J. P.; Sheinfeld, J.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Phase I study of CT-2106 (polyglutamate camptothecin) in patients with advanced malignancies
    Meeting Abstract

    Springett, G. M.; Takimoto, C.; McNamara, M.; Doroshow, J. H.; Syed, S.; Eastham, E.; Spriggs, D.; Pezzulli, S.; Michelson, G.; Dupont, J.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • A phase III randomized trial of cisplatin and paclitaxel administered by either 24 hour or 96 hour infusion in patients with selected stage III or stage IV epithelial ovarian cancer (GOG 162)
    Meeting Abstract

    Spriggs, D. R.; Brady, M.; Rubin, S.; Hanley, M.; Copeland, L. J.; Clarke-Pearson, D.; Burger, R.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save